These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 8680672)

  • 21. Mucus clearance and lung function in cystic fibrosis with hypertonic saline.
    Donaldson SH; Bennett WD; Zeman KL; Knowles MR; Tarran R; Boucher RC
    N Engl J Med; 2006 Jan; 354(3):241-50. PubMed ID: 16421365
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of nebulized albuterol on blood glucose in patients with diabetes mellitus with and without cystic fibrosis.
    König P; Goldstein D; Poehlmann M; Rife D; Ge B; Hewett J
    Pediatr Pulmonol; 2005 Aug; 40(2):105-8. PubMed ID: 15965894
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Improved respiratory system conductance following bronchodilator predicts reduced exertional dyspnoea.
    Diba C; King GG; Berend N; Salome CM
    Respir Med; 2011 Sep; 105(9):1345-51. PubMed ID: 21482091
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of levalbuterol metered dose inhaler in pediatric patients with asthma: a double-blind, randomized, placebo- and active-controlled trial.
    Berger WE; Milgrom H; Skoner DP; Tripp K; Parsey MV; Baumgartner RA;
    Curr Med Res Opin; 2006 Jun; 22(6):1217-26. PubMed ID: 16846555
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect on lung function and morning activities of budesonide/formoterol versus salmeterol/fluticasone in patients with COPD.
    Partridge MR; Schuermann W; Beckman O; Persson T; Polanowski T
    Ther Adv Respir Dis; 2009 Aug; 3(4):1-11. PubMed ID: 19734176
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Efficacy, tolerability, and effect on asthma-related quality of life of formoterol bid via multidose dry powder inhaler and albuterol QID via metered dose inhaler in patients with persistent asthma: a multicenter, randomized, double-blind, double-dummy, placebo-controlled, parallel-group study.
    Busse W; Levine B; Andriano K; Lavecchia C; Yegen U
    Clin Ther; 2004 Oct; 26(10):1587-98. PubMed ID: 15598475
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A crossover, randomized, controlled trial of dornase alfa before versus after physiotherapy in cystic fibrosis.
    Fitzgerald DA; Hilton J; Jepson B; Smith L
    Pediatrics; 2005 Oct; 116(4):e549-54. PubMed ID: 16147970
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Tiotropium bromide, a new long-acting antimuscarinic bronchodilator: a pharmacodynamic study in patients with chronic obstructive pulmonary disease (COPD). Dutch Study Group.
    Maesen FP; Smeets JJ; Sledsens TJ; Wald FD; Cornelissen PJ
    Eur Respir J; 1995 Sep; 8(9):1506-13. PubMed ID: 8575576
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Hyperpolarized HHe 3 MRI of the lung in cystic fibrosis: assessment at baseline and after bronchodilator and airway clearance treatment.
    Mentore K; Froh DK; de Lange EE; Brookeman JR; Paget-Brown AO; Altes TA
    Acad Radiol; 2005 Nov; 12(11):1423-9. PubMed ID: 16253854
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intermittent administration of inhaled tobramycin in patients with cystic fibrosis. Cystic Fibrosis Inhaled Tobramycin Study Group.
    Ramsey BW; Pepe MS; Quan JM; Otto KL; Montgomery AB; Williams-Warren J; Vasiljev-K M; Borowitz D; Bowman CM; Marshall BC; Marshall S; Smith AL
    N Engl J Med; 1999 Jan; 340(1):23-30. PubMed ID: 9878641
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pilot study assessing the effect of bronchodilator on dynamic hyperinflation in LAM.
    Baldi BG; de Albuquerque AL; Pimenta SP; Salge JM; Kairalla RA; Carvalho CR
    Respir Med; 2013 Nov; 107(11):1773-80. PubMed ID: 24064347
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of salbutamol on lung function and chest wall volumes at rest and during exercise in COPD.
    Aliverti A; Rodger K; Dellacà RL; Stevenson N; Lo Mauro A; Pedotti A; Calverley PM
    Thorax; 2005 Nov; 60(11):916-24. PubMed ID: 15994253
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of regular salmeterol treatment on albuterol-induced bronchoprotection in mild asthma.
    Yates DH; Worsdell M; Barnes PJ
    Am J Respir Crit Care Med; 1997 Sep; 156(3 Pt 1):988-91. PubMed ID: 9310023
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of regular inhaled albuterol on exercise-induced bronchoconstriction.
    Inman MD; O'Byrne PM
    Am J Respir Crit Care Med; 1996 Jan; 153(1):65-9. PubMed ID: 8542164
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
    Boscia JA; Pudi KK; Zvarich MT; Sanford L; Siederer SK; Crim C
    Clin Ther; 2012 Aug; 34(8):1655-66.e5. PubMed ID: 22789766
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of effects of 3 and 7% hypertonic saline nebulization on lung function in children with cystic fibrosis: a double-blind randomized, controlled trial.
    Gupta S; Ahmed F; Lodha R; Gupta YK; Kabra SK
    J Trop Pediatr; 2012 Oct; 58(5):375-81. PubMed ID: 22374985
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effect of age on bronchodilator response.
    Kradjan WA; Driesner NK; Abuan TH; Emmick G; Schoene RB
    Chest; 1992 Jun; 101(6):1545-51. PubMed ID: 1534742
    [TBL] [Abstract][Full Text] [Related]  

  • 38. No paradoxical bronchodilator response with forced oscillation technique in children with cystic fibrosis.
    Hellinckx J; De Boeck K; Demedts M
    Chest; 1998 Jan; 113(1):55-9. PubMed ID: 9440568
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A three-month comparison of twice daily inhaled formoterol versus four times daily inhaled albuterol in the management of stable asthma.
    Kesten S; Chapman KR; Broder I; Cartier A; Hyland RH; Knight A; Malo JL; Mazza JA; Moote DW; Small P
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):622-5. PubMed ID: 1892303
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter randomized controlled trial of withdrawal of inhaled corticosteroids in cystic fibrosis.
    Balfour-Lynn IM; Lees B; Hall P; Phillips G; Khan M; Flather M; Elborn JS;
    Am J Respir Crit Care Med; 2006 Jun; 173(12):1356-62. PubMed ID: 16556691
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.